EdgarLookup

Cormorant Global Healthcare Master Fund, LP

Insider transactions at 10 companies

This page shows all SEC Form 4 filings attributed to Cormorant Global Healthcare Master Fund, LP. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

APLS OLMA MLTX EYPT DRUG JBIO IMRX CRBP BMEA OKUR
Company Title Type Shares Price Value Date
MLTX Sale 2,800,000 $6.61 $18,508,000 Sep 29, 2025
OKUR Sale 24,300 $1.99 $48,357 May 12, 2025
DRUG Purchase 39,743 $23.22 $922,832 Oct 15, 2024
CRBP Purchase 47,564 $21.47 $1,021,199 Sep 20, 2024
EYPT Purchase 395,244 $17.62 $6,964,199 Apr 18, 2024
IMRX Sale 345,266 $3.24 $1,118,662 Mar 14, 2024
EYPT Purchase 19,866 $33.75 $670,478 Dec 4, 2023
BMEA Purchase 400,000 $30.00 $12,000,000 Mar 30, 2023
0001827087 C 616,786 Jan 11, 2022
0001786255 C 426,393 Aug 2, 2021
JBIO Purchase 500,000 $14.00 $7,000,000 Jul 2, 2021
0001840574 C 709,224 Jun 21, 2021
0001718852 C 1,848,022 Mar 16, 2021
OLMA C 2,845,544 Nov 23, 2020
APLS Purchase 1,071,428 $14.00 $14,999,992 Nov 13, 2017